283 related articles for article (PubMed ID: 2396838)
1. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
Lane PR; Moreland AA; Hogan DJ
Arch Dermatol; 1990 Sep; 126(9):1211-3. PubMed ID: 2396838
[TBL] [Abstract][Full Text] [Related]
2. Penile verrucous carcinoma.
Yeager JK; Findlay RF; McAleer IM
Arch Dermatol; 1990 Sep; 126(9):1208-10. PubMed ID: 2396837
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
Geraldez CB; Gutierrez GT
Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
[TBL] [Abstract][Full Text] [Related]
4. Actinic prurigo--a specific photodermatosis?
Addo HA; Frain-Bell W
Photodermatol; 1984 Jun; 1(3):119-28. PubMed ID: 6527952
[TBL] [Abstract][Full Text] [Related]
5. Intermittent treatment of psoriasis with clobetasol propionate.
Hradil E; Lindström C; Möller H
Acta Derm Venereol; 1978; 58(4):375-7. PubMed ID: 82342
[TBL] [Abstract][Full Text] [Related]
6. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
7. Atrophic skin striae following the use of clobetasol propionate ointment.
Hardie RA; Waring AJ; Barnetson RS
Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
[No Abstract] [Full Text] [Related]
8. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
9. The use and abuse of 0.05 per cent clobetasol propionate in dermatology.
Harris DW; Hunter JA
Dermatol Clin; 1988 Oct; 6(4):643-7. PubMed ID: 3229014
[TBL] [Abstract][Full Text] [Related]
10. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
11. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
Svartholm H; Larsson L; Frederiksen B
Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison between a new trihalogenated dermatocorticosteroid (halometasone) cream and clobetasol 17-propionate (Dermovate) cream.
Schwarz KJ; Konzelmann M; Yawalkar SJ; Schoenenberger PM
Br J Clin Pract; 1982 May; 36(5):192-6. PubMed ID: 6756453
[No Abstract] [Full Text] [Related]
13. Contact allergy to clobetasol propionate.
Cox NH
Arch Dermatol; 1988 Jun; 124(6):911-3. PubMed ID: 2967675
[TBL] [Abstract][Full Text] [Related]
14. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
15. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
Eriksen K
Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
Madan V; August PJ; Chalmers RJ
Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
[No Abstract] [Full Text] [Related]
19. Adrenal suppression following low-dose topical clobetasol propionate.
Ohman EM; Rogers S; Meenan FO; McKenna TJ
J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
[TBL] [Abstract][Full Text] [Related]
20. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
